Making the Right Choices for Patients with Ulcerative Colitis
From GI Insights by ReachMD
January 22, 2026 · 14 min
About this episode
Dr. Peter Buch discusses with Dr. David Hudesman the evolving treatment options for ulcerative colitis and how to personalize patient care.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: David P. Hudesman, MD Ulcerative colitis treatment continues to evolve with a growing range of targeted therapies, from S1P modulators to JAK inhibitors. Joining Dr. Peter Buch to discuss how clinicians can personalize care based on disease severity, safety profiles, and patient response is Dr. David Hudesman. He's a Professor in the Department of Medicine at NYU Grossman School of Medicine and the Director of NYU Langone’s Inflammatory Bowel Disease Center.
People in this episode
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: David P. Hudesman, MD
Topics covered
- ulcerative colitis
- targeted therapies
- personalized care
- disease severity
- safety profiles
- patient response
Keywords
- ulcerative colitis
- treatment
- targeted therapies
- S1P modulators
- JAK inhibitors
- personalized care
- disease severity
Mentioned in this episode
Organizations: NYU Grossman School of Medicine, NYU Langone’s Inflammatory Bowel Disease Center
More episodes of GI Insights
- Strategies for Increasing Colorectal Cancer Screening Rates · April 30, 2026 · 9 min
- Assessing Racial Disparities in Colorectal Cancer Screening · April 30, 2026 · 15 min
- Colorectal Cancer in Young Patients: A Multidisciplinary Approach · April 30, 2026 · 12 min
- Recapping the 2021 ACG Clinical Guidelines: What’s New in Colorectal Cancer Screening? · April 30, 2026 · 13 min
- Adenoma Detection Rate: A Prediction of Colorectal Cancer · April 30, 2026 · 14 min
- Developments in Colorectal Cancer Screening: Cell-Free DNA Blood Testing · April 30, 2026 · 11 min
Explore listener stats, chart rankings, contacts and more on the GI Insights podcast page.